| Literature DB >> 25410117 |
Piotr Janusz1, Malgorzata Kotwicka, Miroslaw Andrusiewicz, Dariusz Czaprowski, Jaroslaw Czubak, Tomasz Kotwicki.
Abstract
BACKGROUND: The age at menarche (AAM) is commonly in use in patients with IS as one of the maturity indicator suggesting deceleration of the growth velocity. The AAM was suggested to be related to predisposition and curve progression potential of IS. The late age at menarche was reported to be associated with higher prevalence of adolescent idiopathic scoliosis. The age at menarche is determined by both genetic and environmental factors as well as their interactions. Estrogen receptors 1 and 2 polymorphism were reported to be associated with AAM: in ESR1 XbaI and PvuII site polymorphism and in ESR2 AluI site polymorphism.The purpose of the study was to investigate associations of the ESR1 and ESR2 polymorphisms with AAM in IS patients and to evaluate association of AAM with IS severity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25410117 PMCID: PMC4247216 DOI: 10.1186/1471-2474-15-383
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Patients description, N = 208
| Parameter | Mean ± SD | Min - Max |
|---|---|---|
| Age at examination [months] | 201.5 ± 70.6 | 148 - 654 |
| Cobb angle [°] | 40.2 ± 18.2 | 20 - 114 |
| Height [cm] | 164.2 ± 7.0 | 149 - 181 |
| Weight [kg] | 51.0 ± 9.2 | 35 - 79 |
| BMI [m/kg2] | 18.9 ± 2.8 | 13.7 - 27.5 |
| Age at Menarche [months] | 154.8 ± 14.7 | 121 - 192 |
Primers’ description
| Gene | SNP | Enzyme | 5’- > 3’ | Sequence 5’- > 3’ | Annealing temp | Amplicon length |
|---|---|---|---|---|---|---|
| ESR1 | rs9340799 |
| F | CTGCCACCCTATCTGTATCTTTTCCTATTCTCC | 71°C | 1300 bp |
| R | TCTTTCTCTGCCACCCTGGCGTCGATTATCTGA | |||||
| rs2234693 |
| F | AGGCTGGGCTCAAACTACAG | 60°C | 759 bp | |
| R | TCCTTGGCAGATTCCATAGC | |||||
| ESR2 | rs1256049 |
| F | TTCTGAGCCGAGGTCGTAGT | 66°C | 582 bp |
| R | TGAATCCTTGGACCCAACTC | |||||
| rs4986938 |
| F | GTGTGTGGTGGGACACAGAG | 65°C | 646 bp | |
| R | AGGCCATTGAGTGTGGAAAC |
RFLP enzymes description
| SNP | Enzyme | Position | Recognition site 5’- > 3’ | Allele | Digestion product length | |
|---|---|---|---|---|---|---|
| rs9340799 |
| ESR1 | T*CTAGA | T*CT | A | 910 bp + 390 bp |
| Intron 1 | TCT | G | 1300 bp | |||
| 351A > G | ||||||
| rs2234693 |
| ESR1 | CAG*CTG | CAG*C | T | 271 bp + 488 bp |
| Intron 1 | CAGC | C | 759 bp | |||
| 397C > T | ||||||
| rs4986938 |
| ESR2 | AG*CT |
| A | 445 pz + 201 pz |
| UTR |
| G | 646 pz | |||
| 1730G > A | ||||||
| rs1256049 |
| ESR2 | GT*AC | GT* | A | 293 pz + 289 pz |
| Exon 5 | GT | G | 582 pz | |||
| 1082G > A |
*Digestion site.
Figure 1Example of PCR products electrophoresis for rs4986938 M – Nova 100 bp DNA ladder size standard (Novazym®), 1–8 – patients DNA.
Figure 2Example of enzyme RFLP products electrophoresis for rs4986938 1–8 – patients’ DNA. M - Nova 100 bp DNA Ladder size standard (Novazym®) (samples 1 and 4 were homozygotes AA genotype – in both alleles enzymatic restriction occurred; sample 5–7 - was homozygote GG genotype – in both alleles enzymatic restriction did not occur; samples 2,3 and 8 – were heterozygotes AG genotype – in one allele enzymatic restriction occurred and in the other did not).
Genotypes distribution, mean and SD values of the AAM for all patients, N = 208
| SNP | HWE | Genotype | Mean ± SD | Min - Max | P |
|---|---|---|---|---|---|
|
| 0.7429a | AA N = 71 | 153.8 ± 13.4 | 129 - 191 | 0.7141b |
| AG N = 103 | 155.6 ± 15.9 | 121 - 192 | |||
| GG N = 34 | 154.2 ± 13.4 | 130 - 184 | |||
|
| 0.9733a | CC N = 47 | 154.4 ± 14.2 | 130 - 192 | 0.9774b |
| CT N = 104 | 154.8 ± 15.7 | 121 - 192 | |||
| TT N = 57 | 155.0 ± 13.3 | 129 - 191 | |||
|
| 0.7415a | AA N = 26 | 153.1 ± 14.2 | 132 - 188 | 0.7973b |
| AG N = 92 | 155.3 ± 14.4 | 128 - 192 | |||
| GG N = 90 | 154.8 ± 15.2 | 121 - 187 | |||
|
| 0.4206a | AG N = 22 | 151.2 ± 13.7 | 131 - 180 | 0.2282c |
| GG N = 186 | 155.2 ± 14.8 | 121 - 192 |
aChi2 test; bANOVA t; ct-Student test.
Figure 3The mean age at menarche in patients divided according to Cobb angle, p > 0.05.
Mean AAM in patients with mild scoliosis versus patients with severe scoliosis
| Cobb angle | N | Mean ± SD [months] | Min – Max [months] | P |
|---|---|---|---|---|
| <30° | 67 | 151.9 ± 14.7 | 121 - 188 | 0.0267a |
| ≥50° | 51 | 157.9 ± 14.0 | 121 - 191 |
at-Student test.